Recbio Technology's Chair Steps Down; Successor Named

MT Newswires Live
2025/12/23

Jiangsu Recbio Technology's (HKG:2179) Chairman Liu Yong resigned to dedicate more time to other commitments, a Tuesday Hong Kong bourse filing said.

Liu will continue to serve as the vaccine maker's general manager.

The firm, on Tuesday, named Xu Haoyu as its new chairman.

Xu has been the chairman and president of Yangtze River Pharmaceutical (Group) since July 2021.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10